MAPT and Cognitive impairment: Threonine231 (Thr231) is another important phosphorylation site in tau protein that is phosphorylated or hyperphosphorylated in the cerebrospinal fluid of AD patients, and is correlated with memory loss and progression of AD from mild to severe cognitive impairments.[56]